Pharmaceutical solution comprising dopamine for use in treating parkinson's disease
US10105326B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 12, 2015 |
| Grant date | Oct 23, 2018 |
| Priority date | — |
| Expiry date | May 12, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical solution is kept under anaerobic conditions from its formulation to its administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.